Abstract Figure: Increasing collagen stiffness causes a shift in highly invasive MDA-MB231 cancer cells from glycolysis to oxidative phosphorylation. Glioma U251MG cells show an opposite trend and MCF10A non-tumorigenic cells have little change in metabolism signatures in response to substrates stiffness. 
Summary
Extracellular matrix (ECM) mechanical properties play a key role in cancer cell aggressiveness. Increasing substrate stiffness upregulates cancer invasion, cell contractility and focal adhesion formation. In addition to matrix properties, alteration in energy metabolism is a known characteristic of cancer cells (i.e., Warburg effect) and modulates cell invasion. However, there has been little evidence to show that substrate stiffness is able to affect cancer cell metabolism. Thus, we investigated changes in energy metabolism in response to varying collagen matrix stiffness in different cancer cells, MDA-MB231, AA375MM and U251MG and non-tumorigenic breast cell line MCF10A. Using the phasor approach to fluorescent lifetime imaging microscopy (FLIM), we measured the lifetime ratio of the free:bound state of NADH and determined if these cells altered their metabolism when plated on varying ECM density. This approach is a powerful tool that allows us to map the metabolic trajectory of each living cell within its cellular compartments. In our studies, we found that MDA-MB231 cells had an increase in bound NADH, indicating oxidative phosphorylation (OXPHOS), as collagen substrate density decreased. When inhibiting myosin-II contractility with Y-27632 or blebbistatin, the MDA-MB231 cells on glass shifted from glycolysis (GLY) to OXPHOS, confirming the intricate relationship between mechanosensing and metabolism in these highly invasive tumor cells. The human glioblastoma cell line, U251MG, showed an opposite trend compared to the invasive MDA-MB231 cells. However, the human melanoma cell line, A375MM did not show any significant changes in metabolic indices when they were grown on surfaces with varying collagen density but changed when grown on glass surfaces. MCF10A cells showed no changes in metabolism across all surfaces. In addition, OXPHOS or GLY
Introduction
Cancer cells can modulate their energy metabolism to meet nutritional, biosnynthesis and respiration requirements for maintaining malignancy. One of these factors is the metabolic state of the cancer cell due to their tendency to undergo aerobic glycolysis, known as the Warburg Effect (Vander Heiden et al., 2009; Liberti and Locasale, 2016; Warburg et al., 1927) . Although it produces less ATP per molecule of glucose, glycolysis (GLY) is a more rapid way of producing ATP and is able to meet the high demands of energy to fuel processes such as invasion, migration, and matrix degradation (Caino et al., 2015; Cunniff et al., 2016; Desai et al., 2013; Zhao et al., 2013) . Along with high turnover of ATP production, a byproduct of lactic acid and high acidification also has been shown to benefit cancer cell survival and upregulate invasiveness (Estrella et al., 2013) .
Mechanical properties of the extracellular matrix (ECM) is also a known factor that regulates cell migration and cancer invasion (Alexander et al., 2008; Artym et al., 2015; Paszek et al., 2005; Seewaldt, 2014; Wells, 2008) . Cells interact with the surrounding ECM through integrin-mediated adhesions and focal adhesions (FAs) , that are clusters of over 150 proteins (Kanchanawong et al., 2010; Liu et al., 2015) . These complexes tether to the cell's mechanosensing network through actin filaments and regulate processes such as adhesion, migration, and proliferation (Bugyi and Carlier, 2010; Gardel et al., 2010; Hirata et al., 2014; Ponti et al., 2004) . Recent studies have shown that integrin-mediated adhesion interact with the metabolic pathway of the cell through the PI3K/AKT/mTOR pathway and that this could be a potential method of switching the Warburg effect (Ata and Antonescu, 2017; Levental et al., 2009; Yang et al., 2015) . Many of these studies use biochemical assays which are invasive and often lose information which exist in live cell samples. In our approach, we used a non-invasive fluorescent imaging technique to measure ECM density, study live cell behavior and map energy metabolism within each cell.
Fluorescent lifetime imaging microscopy (FLIM) has been shown to be a powerful technique to measure metabolic indices of live-cells (Bird et al., 2005; Cinco et al., 2016; Datta et al., 2015; Ma et al., 2016; Provenzano et al., 2009; Sameni et al., 2016; Stringari et al., 2012) . By looking at the fluorescent lifetime of nicotinamide adenine dinucleotide (NADH), a metabolite involved in OXPHOS and GLY, we can determine the population of free and bound NADH due to their difference in lifetime decay. This will allow us to quantify the "metabolic trajectory", known as the "M trajectory", of the cell at every pixel of our image and determine if the cell is undergoing OXPHOS or GLY . The advantage of this imaging technique is that it is non-invasive and is able to image real-time changes in metabolism.
For this study, we measured free and bound populations of NADH within different cancer cell lines and a non-tumorigenic cell line when seeded on collagen substrates of different concentrations (1.2 mg/mL and 3.0 mg/mL) and on glass. The microstructural properties of this substrate, including collagen density and fiber diameter, were measured using image correlation spectroscopy (Raub et al., 2008) . The 3.0 mg/mL and 1.2 mg/mL collagen substrate had collagen fibers of similar size, but the 3.0 mg/mL collagen substrate gave rise to a denser ECM than the 1.0 mg/mL substrate by 3X. The 3.0 mg/mL collagen substrate was also determined by rheology to be one order of magnitude stiffer than the 1.2 mg/mL collagen substrate. The highly metastatic breast cancer cell line MDA-MB21 showed a shift towards a more glycolytic signature as substrate stiffness increased.
Inhibition of cell contractility with addition of Y-27632 shifted all the cells on all substrates to a more OXPHOS signature compared to their uninhibited controls. In addition, we observed more stable focal adhesions on our stiffer substrates through raster image correlation analysis by measuring the diffusion of talin-GFP, focal adhesion protein which binds to integrin and the actin cytoskeleton structure. This further shows that integrin mediated adhesions behave as mechanosensors and these adhesions can alter metabolism.
Non-tumorigenic breast cell line MCF10A showed no significant changes in NADH free:bound ratio across all surfaces, indicating that this property only appears in MDA-MB231 cell lines. Other cancer cell types, U251MG glioma and A375MM melanoma cell lines, were evaluated under the same conditions. The U251MG cells had an opposite trend of NADH free:bound ratio signatures across the substrates compared to MDA-MB231 cells. A375MM cells did not adhere well to the collagen substrates which caused them to have no significant difference in their NADH free:bound ratio; which indicates that the mechanosensing network must be established in order to undergo metabolic reprogramming. Inhibition of OXPHOS or GLY in MDA-MB231 cells showed shifts in NADH free:bound ratio with respect to each treatment towards their metabolic counterparts across all surfaces, and further confirmed that it is indeed the metabolism that is being altered by the ECM. MCF10A cells showed a shift when OXPHOS was inhibited only on our denser collagen and on glass substrates when GLY was inhibited.
The results found in our work here show that both the mechanosensing and metabolism pathways are interconnected and can be modulated through ECM mechanical properties.
This will provide further information to develop cancer therapies which target either or both of these pathways to decrease cancer cell invasion.
Results

Collagen characterization measurements
Tilghman et al. postulated that cellular metabolism can be altered when MDA-MB231 cells are cultured on soft (300 Pa) versus stiff (19200 Pa) matrices due to the fact that cells stayed in the G1 phase cell cycle phase longer (Tilghman et al., 2012) . Indeed, their results using cell lysates with ATPlite assay and protein synthesis assays confirmed their hypothesis. The substrates used in those experiments were limited to polyacrylamide gels that have a large rigidity/flexibility range, but it is not physiological. In our approach, we used collagen monolayers prepared at two different concentrations of 1.2 mg/mL and 3.0 mg/mL Second harmonic generation (SHG) images were taken to measure the fiber thickness, and density was measured using image correlation spectroscopy (ICS). Previously in our lab, we have shown that mechanical properties of collagen obtained through SHG and ICS correlated to those obtained by rheology or scanning electron microscopy images (Chiu et al., 2013; Raub et al., 2008) . For this analysis, the ωo value gives the waist of the auto correlation function and based on the size of the point spread function of the laser (~0.3 µm at the waist). A larger ωo indicates thicker fibers. 1/G(0) quantified the density of the matrix which is the height of the auto correlation function extrapolated from the first measured point. A smaller 1/G(0) value corresponds to denser matrices. 3.0 mg/mL and 1.2 mg/mL collagen substrates showed similar average values of ωo of 2.55 and 2.29 ( Figure 1C) . However, the 3.0 mg/mL collagen has a significantly larger average value of 1/G(0) of 5.54 compared to that of the 1.2 mg/mL collagen at 1.09 ( Figure 1D ). This confirms that the 3.0 mg/mL collagen substrates have a denser network of collagen although their fiber thicknesses are similar.
Rheology measurements were also done to quantify the modulus of the substrates. collagen substrate stiffness. NADH has two different lifetimes when it is free in the cytosol, ~0.4 ns, or bound to a protein, ranging from ~1.4 ns to 9 ns (Jameson et al., 1989; Lakowicz et al., 1992; Skala et al., 2007) . Thus, we are able to distinguish the ratio of free and bound NADH at each pixel. For our studies, the lifetime of NADH bound to lactate dehydrogenase (LDH, ~3.4 ns) is used when quantifying the population of bound NADH, although there are many other possible enzymes (Datta et al., 2015; Ma et al., 2016) (Digman et al., 2008a; Stringari et al., 2012) . Highly invasive MDA-MB231 cells were seeded on collagen and glass substrates to observe changes in free:bound ratios of NADH. In addition, the free:bound ratio of NADH in non-tumorigenic breast cells MCF10A were used as a control for a nontumorigenic cell line. MDA-MB231 cells showed a 6.2% and 11.4% increase of bound NADH on 3.0 mg/mL and 1.2 mg/mL substrates, respectively, relative to those on glass ( Figure 2B ). This indicates that as substrate stiffness increased, the MDA-MB231 cells shifted from OXPHOS (white/cyan) to GLY (pink/red) ( Figure 2C ). MDA-MB231 cells on glass were then treated with 10 µM Y-27632, a ROCK inhibitor that decreases cell contractility, to assess if inhibiting the cell's mechanosensing ability would shift the metabolism towards OXPHOS. Indeed, we see a significant change in the metabolic index (5.7% increase in bound NADH) in these cells when Y-27632 was added ( Figure   2B ). Similar results were seen on MDA-MB231 cells on glass when treated with 3.5 µM blebbistatin, showing a 14.4% increase relative to untreated glass samples (Supplementary Figure S1) . We also used both treatments on MDA-MB231 cells plated on 1.2 mg/mL and 3.0 mg/mL collagen and detected an increase in the bound NADH population as well (Supplementary Figure S2) . MCF-10A cells did not show this shift in metabolism in response to substrate stiffness, but did show an increase in the population of bound NADH with the addition of Y-27632 on glass ( Figure 2B&C ). We also examined other cancer cell lines to determine if they also had the same response to collagen stiffness. These results are shown below.
Melanoma, A375MM, and glioblastoma, U251MG, cell lines showed different results than that of the MDA-MB231 cells. A375MM cells shows no significant change in free:bound ratio of NADH when on the 1.2 mg/mL or 3.0 mg/mL collagen substrates or glass ( Figure 3A&B ). We noticed that these cells did not adhere as well on the collagen substrates due to their round morphology ( Figure 3C ) which could be the reason why there was no change in metabolism as seen in the MDA-MB231 cells. This further supports our hypothesis that the mechanosensing pathway plays an important role in cancer cell metabolism. On the other hand, the U251MG cells showed opposite changes to that of MDA-MB231 cells with 3.4% and 1.6% decrease in bound NADH relative to glass on 3.0 mg/mL and 1.2 mg/mL collagen, respectively ( Figure 3B ). Thus, they showed increased glycolytic signatures as substrate stiffness decreased, although the changes were not significant. Previous studies have also shown that MDA-MB231 and U251MG have opposite trends of matrix degradation and invadopodia formation when they are cultured in different media supplemented with GLY or OXPHOS inhibitors (Van Horssen et al., 2013) . This may explain our results, but further studies will need to be conducted to confirm them. Generally, the nucleus of the cell lines has a more GLY signature than the cytoplasm, but this did not significant effect the results we found when looking at the entire cell within MDA-MB231 and MCF10A cells. However, within A375MM cells seeded on 3.0 mg/mL or 1.2 mg/mL collagen substrates, their populations of bound NADH were similar; but when looking at their nuclei and cytoplasmic, we began to see a separation between the two conditions, especially in the nuclei alone. The nuclei in A375MM cells on 3.0 mg/mL collagen substrates show a shift towards GLY where their population of bound NADH decreased by 24.5% compared to those on glass. U251MG cell nuclei metabolic indices were similar on all surfaces except for those on glass and treated with blebbistatin, which show a 10.6 decrease in the population of bound NADH.
The rest of this report will focus mainly on the MDA-MB231 and MCF10A cells to compare results of cancerous and non-tumorigenic cell lines. In order to confirm that the fraction of free:bound ratio of NADH is modulated through substrate stiffness, we conducted metabolism inhibition studies of each cell line when seeded on both collagen and glass substrates.
Metabolism inhibition studies confirm that GLY and OXPHOS are modulated by substrate stiffness In order to ensure that the collagen density alters metabolism in MDA-MB231 and MCF10A cells and that these changes correlate with lifetime positions along the M trajectory, we treated these cell lines with oxidative phosphorylation and glycolysis inhibitors. We treated MDA-MB231 cells with 50 mM 2-deoxyglucose and 100 mM dichloroacetate (2DG&DCA) for GLY inhibition and 50 nM rotenone and 50 nM antimycin A (R&A) for OXPHOS. 2DG&DCA treatment showed an increased population of bound NADH of 25.43%, 16.01% and 12.98% for cells plated on glass, 3.0 mg/mL collagen, and 1.2 mg/mL collagen surfaces, respectively, relative to untreated cells ( Figure 4C ). When MDA-MB231 cells were treated with R&A on 3.0 mg/mL and 1.2 mg/mL collagen substrates, they showed significant decreases in the population of bound NADH, p<0.05, of 11.5% and 11.35%, respectively, relative to untreated cells. However, there was no change when these cells plated on glass were inhibited with R&A. These treatments were also applied to MCF10A cells where we observed a significant decrease in the population of bound NADH only on 3.0 mg/mL collagen substrates, 5.52%, and glass, 5.93%, when treated with R&A ( Figure 4D ). No changes were seen on the 1.2 mg/mL collagen substrates. However, there was a significant increase of 3.32% on these cells when plated on 1.2 mg/mL collagen and treated with 2DG and DCA. In order to correlate our finding of substrate stiffness to the stability of focal adhesions dynamics in cells, we analyzed the diffusion of talin-GFP, a protein associated with integrin mediated adhesions and the actin cytoskeleton, by using RICS, raster image correlation spectroscopy Digman et al., 2008b Liang et al., 2017) . In our previous work we demonstrated that increased spatio-temporal focal adhesion diffusion of proteins at the focal adhesions indicated active adhesion association and dissociation whereas stable adhesions had a steady state population. By measuring the diffusion of talin at the FA, we can observe the motility and stability of the adhesions. We hypothesized that MDA-MB231 on stiffer matrices would show a decreased diffusion of talin-GFP due to increased FA stability. We imaged MBA-MB231 cells transiently transfected with talin-GFP and observed an increase of diffusion with substrates stiffness (Supplementary Figure S5b) . Talin-GFP of MDA-MB231 cells on glass had a diffusion rate of 0.71 m 2 /sec where the cells on the 3.0 and 1.2 mg/mL collagen substrates had rates of 3.40 m 2 /sec and 4.62 m 2 /sec, respectively. Cells were treated with Y-27632, a specific inhibitor of kinase (ROCK) and cell contractility, to the disruption of the mechanical tension (Martin et al., 2016) . These cells had an increased diffusion of talin-GFP of 2.04 m 2 /sec.
Discussion
The Warburg effect is the hallmark for cancer cell metabolism, described as an oncogene-directed glycolytic state even when oxygen is present (Vander Heiden et al., 2009; Liberti and Locasale, 2016; Ward and Thompson, 2012) . This could be due to the high turnover of ATP production through glycolysis for energy production with glucose, although the alternative process of oxidative phosphorylation creates more product of energy per glucose molecule. Cancer cell invasion has also been shown to be modulated by changes in metabolism through changing cell media additives for energy consumption (Van Horssen et al., 2013; Scott et al., 2012) or the ECM stiffness (Artym et al., 2015; Gould and Courtneidge, 2014; Paszek et al., 2005; Provenzano et al., 2008; Seewaldt, 2014) . However, the link between ECM stiffness and cell metabolic state (OXPHOS or GLY) is not clear. Recent studies that look at alterations of metabolism use invasive biochemical assays that do not report the spatial heterogeneous changes of metabolic response within cellular compartments, nor their cellular metabolic state. Our study used FLIM of NADH to measure real-time metabolic indexes of different cancer cell types in response to collagen substrate stiffness. This allows us to characterize which metabolic process occurs with pixel resolution in live cells.
We have found that MDA-MB231 cells on substrates on two different collagen stiffnesses have an increasing population of free NADH, showing a more glycolytic signature of metabolism. This correlates with previous studies in that breast cancer cells have increased migration and aggressiveness within stiffer collagen matrices (Haage and Schneider, 2014; Levental et al., 2009; Paszek et al., 2005) . In addition, cancer cells undergo aerobic glycolysis for energy production, thus increased substrate stiffness could be a contributor to the metabolic shift towards glycolysis (Liberti and Locasale, 2016; Morris et al., 2016) . The ECM plays a key role in the cancer cell's mechanosensing pathway through integrin signaling, and there is increasing evidence that this regulates cell migration and matrix degradation (Alexander et al., 2008; Beaty et al., 2013; Chiu et al., 2013; Van Horssen et al., 2013) . Increased ECM stiffness signals actin polymerization, increased integrin signaling, and stabilization of the focal adhesion complexes (Ciobanasu et al., 2013; Gardel et al., 2010; Hirata et al., 2014) . This increase of integrin signaling has been shown to also upregulate the PI3K/AKT/mTOR pathways and possible metabolism switching in cancer cells (Ata and Antonescu, 2017; Caino et al., 2015; Lien et al., 2016; Yang et al., 2015) . In addition, stimulating the actin-contractility of cells through external forces by shear flow or pulling of the cell membrane increases glucose uptake (Bays et al., 2017; Hayashi et al., 1998) . Bays et al. has shown that this increased glucose uptake was also shown to increase ATP production for actin polymerization and stabilize E-cadherin contacts. Our results expanded on these studies by looking at the specific metabolic indexes of cancer cells when introduced to various substrate stiffness.
We speculate that these same pathways are being activated in the MDA-MB231 cells and are stimulated passively through focal adhesion-mediated interactions with the ECM.
When cells grown on glass substrates were treated with Y-27632 or blebbistatin, we inhibited their ability to undergo contraction through myosin-II and caused focal adhesion detachment from the substrate (Martin et al., 2016) . This in turn showed shifts in metabolic indexes from GLY to OXPHOS in MDA-MB231 and MCF10A cells. This confirms that it is through actin-mediated cell contractility that modulated these shifts in metabolism. Interestingly, the MDA-MB231 cells treated with Y-27632 had a similar NADH free: bound ratio as those grown on 3.0 mg/mL, which could mean that their degrees of contractility were similar to each the respective conditions. Those treated with blebbistatin had a much larger shift towards OXPHOS, surpassing the population of bound NADH of cells grown on 1.2 mg/mL collagen. Since blebbistatin directly affects myosin-II and is more potent than Y-27632, this was as expected. We also used RICS to measure the dynamics of the talin within MDA-MB231 cells to correlate these movements to adhesion stability. Previous studies have shown that stable adhesions have a developed mechanosensing network of actin, and these adhesions can grow in response to forces or increasing substrates stiffness (Bieling et al., 2016; Kim and Wirtz, 2013; Petit and Thiery, 2000; Wells, 2008) . Thus, cells on the stiffest substrates should have the most stable adhesions and a decreased diffusion rate due to lack of unbinding. Increased FAK promotes glucose consumption and play a key role in the OXPHOS and GLY balance within cancer cells (Palorini et al., 2013) . MDA-MB231 cells expressing talin-GFP were imaged over time on each of the substrates, and an area containing the focal adhesions was analyzed with RICS to extract the diffusion of those proteins. Our results show that the cells on the glass substrates contained the slowest diffusion rates of 0.71 m 2 /sec and the fastest of 4.62 m 2 /sec for cells grown on 1.2 mg/mL substrate. This supports our hypothesis that our softest substrates would give rise to faster moving adhesions due to their instability and thus constant unbinding and binding. In addition, it further supports that an upregulation of adhesion through substrates stiffness shifts MDA-MB231 cells towards a glycolytic signature. We saw that when these cells on the glass substrate were treated with Y-27632, had an increased diffusion of 2.05 m 2 /sec from 0.71 m 2 /sec.
The human melanoma cell lines, A375MM, in this study attached to 1.2 mg/mL and 3.0 mg/mL collagen substrates but did not spread as well as all other cells. This was an indication that their adhesions are not stable or favorable on these substrates (Calderwood et al., 2013; Cavalcanti-Adam et al., 2007; Massia and Hubbell, 1991) and their mechanosensing ability could have been compromised and reduced mitochondria activity (Ochsner et al., 2010) . Consequently, this would fail to change the metabolic indexes of these cells as shown in our results; where the NADH free: bound of A375MM on 1.2 mg/mL or 3.0 mg/mL have no significant difference. This phenotype showed that there is a confirmed link between focal adhesion-mediated mechanosensing and cellular metabolism We also measured the NADH free:bound ratio in glioblastoma cells, U251MG, to see if these trends existed in other cancer cell lines. It was found that they had an opposite trend than that of the MDA-MB231 cells. As substrate stiffness increased, the U251MG cells had a more OXPHOS metabolic index, or an increase in bound NADH. Studies done by Van Horssen et. al also showed that MDA-MB231 and U251MG cells had opposite trends in matrix degradation and invadopodia formation when their metabolism is altered either by galactose containing media to inhibit GLY or addition of oligomycin to inhibit OXPHOS (Van Horssen et al., 2013) . It is important to note that there are many other possible uses for pyruvate aside from OXPHOS in the mitochondria. Downstream of GLY are intermediates of the tricarboxyl acid cycle, such as citrate, which allows for synthesis of lipids, proteins and nucleic acids, a demand for highly proliferating cells (DeBerardinis et al., 2008) . There is also fatty acid synthesis through citrate which is shown to correlate with the formation of invadopodia, which are actin rich protrusions used for matrix invasion (Gould and Courtneidge, 2014; Morris et al., 2016; Scott et al., 2012) . In addition, the pentose phosphate pathway could further increase the GLY and fraction of free NADH.
All of the pathways mentioned could be elevated within MDA-MB231 cells, which could contribute to their difference in metabolic trends from the U251MG cells when ECM stiffness is varied.
The MB231 cells have a significant decrease in the fraction of bound NADH when plated on glass, 3.0 mg/mL and 1.2 mg/mL collagen, respectively. We confirmed that the changes with metabolic trajectory were reflective in cellular metabolism using the OXPHOS and GLY inhibitors. When these inhibitors were added, cells shifted their metabolism accordingly to their inhibitors but there were no significant metabolic differences across substrate density within these changes (Supplementary Figure S3A) .
However, the MCF10A cell lines did not show any significant changes across substrate densities in the untreated conditions. They did show substrate sensitivity only when OXPHOS was inhibited. When R&A was added to inhibit OXPHOS to the 3.0 mg/mL and glass substrates in MCF10A cells, there was a maximum decrease to around 64% of the population of bound NADH; however, those on 1.2 mg/mL collagen showed no significant change (Supplementary Figure S3B) . This could mean that on stiffer substrates, these cells were more susceptible to metabolic changes when introduced to inhibitors.
Additionally, this could also indicate that the metabolism of the MCF10A cells was behaving more like the MDA-MB231 cells on stiffer matrices. When 2DG&DCA was added to inhibit GLY in MCF10A cells, we see a significant increase of the population of bound NADH to around 71.2% when grown on 1.2 mg/mL collagen substrate. Since OXPHOS and softer substrates is preferable for the MCF10A cells, this could mean that this ECM provides an extra boost towards OXPHOS pathway when GLY is inhibited.
The phasor approach to FLIM of NADH allows isolation of the metabolic signature within sub-cellular compartments of the cells. Here, we focused on comparing the nuclei and cytoplasm of MDA-MB231, MCF10A, A375MM and U251MG cell lines (Supplementary Figure S4) . We were able to see that the metabolic shifts within the nuclei and cytoplasm of MDA-MB231 and MCF10A cells are similar to their whole cell signature.
However, within A375MM cells we were able to make distinctions of the population of bound NADH between surfaces, which were not detected when averaging over the entire cell. The nuclei of A375MM cells on 3.0 mg/mL collagen substrates has a significant decrease in the population of bound NADH with respect to those on glass. Thus, looking at the nuclear metabolic indexes can separate subtle changes that are hidden in whole cell readings. These distinctions seen could be due to nuclear processes, such as transcription or DNA repair, which has also been shown to affect the ratio of bound and free NADH (Aguilar-Arnal et al., 2016; Wright et al., 2012) .
Conclusion
We have shown that focal adhesion-mediated contractility modulates cell When cell lines which required transfections of talin-GFP (Addgene, Cambridge, MA) were seeded in a 6-well plate at 0.25x10 -6 cells/well overnight at 37 o C, 5% CO2.
Lipofectamine 3000 (Thermofisher Scientific, USA) was used for transfections following manufacture protocol. Briefly, 100 µL of Opti-mem (Thermofisher Scientific, USA) and 5 µL of Lipofectamine 3000 were mixed in a microcentrifuge tube. In a second microcentrifuge tube, 100 µL of Opti-mem, 1 µg of DNA plasmid, and 2 µL/µg of P3000 reagent were mixed together. Both tubes were allowed to sit for 5 minutes at room temperature and then combined. After the transfection mixture was allowed to sit for 25 minutes at room temperature, it was added dropwise to the cells.
Collagen substrate monolayers
Substrates were made on 35 mm glass bottom imaging dishes which were treated for 5 minutes with UV-ozone. 1% v/v of 3-aminopropyltriethoxysilane (APTES) in deionized water were added and allowed to sit for 25 minutes at room temperature. The dishes were washed thoroughly with deionized water and brought to the biosafety hood for sterile handling. 1 mL of sterilized MilliQ water used to rinse the dish before collagen was added.
For collagen preparation, microcentrifuge tubes and reagents used were kept on ice for as long as possible while handling. Collagen I from rat tail (Corning, Corning, NY) was diluted with deionized water such that the final concentration was either 1.2 mg/mL or 3.0 mg/mL. 100 µL of 10X phosphate buffer saline (Thermofisher Scientific, USA) containing phenol red was added dropwise while vortexing as a pH indicator. 5N NaOH was then added dropwise to the mixture with periodic vortexing until the solution became a slight pink (pH~7). The collagen was then added to the treated imaging dish (total volume of 1 mL) and incubated at 20 o C for 1 hour and then at 37 o C, 5% CO2 overnight.
0.25x10 -6 cells were then added to each dish the next day and then allowed to incubate at 37 o C, 5% CO2 overnight again before imaging took place.
Inhibition studies
Contractility inhibition was done with Y-27632 (Selleckchem, US) or blebbistatin (SigmaAldrich, St. Louis, MO) at a working concentration of 10 µM and 3.5 µM, respectively. Each inhibitor was incubated for 10 minutes at room temperature before conducting FLIM/NADH imaging. MDA-MB231 or MCF10A cells were treated with sodium dichloroacetate (Sigma-Aldrich, St. Louis, MO) and 2-deoxyglucose (Sigma-Aldrich, St. Louis, MO) at a working concentration of 100 mM and 50 mM, respectively, for 6 hours at 37°C, 5% CO2 to inhibit glycolysis (Cinco et al., 2016) . Similarly, cells were treated for 10 minutes with 50 nM rotenone and 50 nM antimycin A at 37°C, for oxidative phosphorylation inhibition studies before NADH lifetimes were measured.
Characterization of collagen substrates
Rheology measurements of collagen substrates were conducted to obtain the storage (G') and loss (G") moduli. The collagen substrates were pre-made on 15 mm glass slides that were treated with UVO and APTES as described above. Collagen solutions of 1.2 mg/mL or 3.0 mg/mL was carefully pipetted onto the round glass slides and allowed to incubate at 20 o C for 1 hour and then at 37 o C overnight for 2 nights to mimic culturing conditions for imaging. The glass sides were placed on the stage of the AR-G2 rheometer (TA Instruments, New Castle, DE) that was kept at a constant temperature of 37°C. A sand-blasted parallel plate geometry with a diameter of 25 mm was lowered to a gap distance of 0.3 mm so that it was in close contact with the surface of the collagen. Rheology measurements were conducted at a constant sinusoidal frequency of 1 Hz and 10% peak-to-peak strain and outputs of G' and G" were recorded for a total of 10 minutes. A data point was taken every 60 seconds.
Second harmonic generation imaging of collagen substrates were conducted to characterize substrate density as previously described (Chiu et al., 2013; Raub et al., 2007) . Briefly, 2-photon excitation at 900 nm was used to generate second harmonics of collagen and collected with a bandpass filter at 460/80 nm with external photon-multiplier tubes (H7422P-40, Hamamatsu, Japan) and FastFLIM FLIMBox (ISS, Champaign, IL). 100 frames were collected and analyzed using image correlation spectroscopy on SimFCS (LFD, UCI). Spatial correlations were applied to each pixel at coordinate ( , ) of the complied SHG images with equation (1) pixel. The lifetime decay at each pixel was Fourier transformed and plotted on a phasor plot as previous described where each point on the phasor represents one pixel (Digman et al., 2008a) . Each cell's cluster of phasor points were averaged to obtain their S, G, and fraction bound value. The fraction of bound NADH is calculated based on the fact that any two points on the phasor plot (e.g. 100% free NADH and 100% bound NADH to LDH)
can be connected by a line and any points along that line will be a linear representation of the two extremes. Thus, the experimental data will exist between 100% free NADH and 100% bound NADH, signifying a samples that has a mixture of free and bound NADH.
Those points that are closer to the phasor of bound NADH to LDH will have a higher population of bound NADH.
Focal adhesion imaging analysis MBA-MB231 cells were transfected with talin-GFP and imaged on the Olympus FV1000 or Zeiss 880 microscope. 100 frames were taken at a 256x256 pixels where the pixel size was no more than 90 nm with a dwell time of 4.10 us/pixel for the Olympus or LSM 880, respectively. These images were analyzed with SimFCS using the raster image correlation spectroscopy to a region of interest (ROI) of 64x64 pixels of where the focal adhesions were located. The RICS routine as previously described Digman et al., 2008b; Rossow et al., 2010) . A moving average subtraction of 10 frames was applied to analysis to account for any bulk cell motion. ωo, or the waist of the point spread function, was estimated as 0.3 µm. After generation of the auto correlation function, a fit was applied with the correct imaging parameters and the diffusion of the talin-GFP molecules within the ROI.
Statistical analysis
Statistical significance was determined for experiments with the Student's t-test 
Conflict of Interest
The authors declare that no competing financial interest exists.
